WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

This group comprises preparations used in the treatment of malignant neoplastic diseases, and immunomodulating agents.

Corticosteroids for systemic use, see H02.


L03 IMMUNOSTIMULANTS

Immunosuppressants, see L04A.


L03A IMMUNOSTIMULANTS

Levamisole, which also affects the immune response, is classified in P02CE.


L03AX Other immunostimulants

The DDD for tasonermin is based on single dose treatment.

The DDD of 0.5 mg (P) for histamine dihydrochloride is based on the total dose devided by days of first treatment cycle (42 days).


    ATC code  Name  DDD  U Adm.R Note
    L03AX07 poly I:C    

List of abbreviations

Last updated: 2018-12-13